Mieke M. Timmermans

Decreased expression of ABAT and STC2 hallmarks ER‐positive inflammatory breast cancer and endocrine therapy resistance in advanced disease

Maurice P.H.M. Jansen, Leen Sas, Anieta M. Sieuwerts et al. · Molecular Oncology · 2015 · 63 citations · Full text

Medicine, Endocrinology, Oncology +17

Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

Wendy Onstenk, Jaco Kraan, Bianca Mostert et al. · Molecular Cancer Therapeutics · 2014 · 58 citations · Full text

Medicine, Clinical Sciences, Oncology +16

Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast

Vibeke Kuenen‐Boumeester, Sonja C. Henzen‐Logmans, Mieke M. Timmermans et al. · The Journal of Pathology · 1999 · 50 citations · Full text

Medicine, Oncology, Pathology +17

IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer

Ying-Hui Zhang, Lynn Wester, Jichao He et al. · Oncogene · 2018 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +14

TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer

Dian Kortleve, Dora Hammerl, Mandy van Brakel et al. · Cancer Discovery · 2024 · 11 citations · Full text

Life Sciences, Immunology, Oncology +17